Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -14.04% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 73.06% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -13.48% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -21.30% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 224.85% |
| 10 | Amphastar Pharmaceuticals | 909.16 Mn | 909.16 Mn | 70.32 Mn | -64.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.94% |
| Dec 31, 2025 | -269.23% |
| Sep 30, 2025 | -52.69% |
| Jun 30, 2025 | 4.71% |
| Mar 31, 2025 | 6.41% |
| Dec 31, 2024 | 23.08% |
| Sep 30, 2024 | 60.57% |
| Jun 30, 2024 | -37.38% |
| Mar 31, 2024 | -93.36% |
| Dec 31, 2023 | -92.03% |
| Sep 30, 2023 | -87.08% |
| Jun 30, 2023 | -83.62% |
| Mar 31, 2023 | 37.97% |
| Dec 31, 2022 | -50.37% |
| Sep 30, 2022 | -12.68% |
| Jun 30, 2022 | -49.08% |
| Mar 31, 2022 | -38.56% |
| Dec 31, 2021 | 341.24% |
| Sep 30, 2021 | 133.86% |
| Jun 30, 2021 | 247.08% |